SS
TVGN icon

SBI Securities’s Tevogen Bio Holdings TVGN Stock Holding History

SBI Securities’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452 Buy
+100
New +$1.23K ﹤0.01% 2923
2025
Q4 		– Hold
0
– – – 4011
2025
Q3 		– Hold
0
– – – 4183

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SBI Securities's TVGN Position: Q1 2026 in Review

SBI Securities opened a new position in Tevogen Bio Holdings (TVGN) in Q1 2026: 100 shares worth $452. The stake represents ﹤0.01% of the portfolio and ranks #2923 among its holdings.

30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • SBI Securities held 100 shares of Tevogen Bio Holdings worth $452 as of Q1 2026.
  • Tevogen Bio Holdings was a new SBI Securities position in Q1 2026.
  • Tevogen Bio Holdings made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2923 holding.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.